Fcpm Iii Services B.V. Dyne Therapeutics, Inc. Transaction History
Fcpm Iii Services B.V.
- $678 Billion
- Q2 2024
A detailed history of Fcpm Iii Services B.V. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Fcpm Iii Services B.V. holds 7,845,364 shares of DYN stock, worth $234 Million. This represents 40.83% of its overall portfolio holdings.
Number of Shares
7,845,364
Previous 7,845,364
-0.0%
Holding current value
$234 Million
Previous $223 Billion
24.3%
% of portfolio
40.83%
Previous 31.49%
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
203Shares Held
105MCall Options Held
82.7KPut Options Held
24.8K-
Atlas Venture Life Science Advisors, LLC8.02MShares$239 Million37.7% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$220 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.39MShares$190 Million3.76% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$180 Million3.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$141 Million0.0% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.54B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...